Zeltiq Aesthetics Inc (ZLTQ) : Handelsinvest Investeringsforvaltning scooped up 13,500 additional shares in Zeltiq Aesthetics Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 23,500 shares of Zeltiq Aesthetics Inc which is valued at $869,265.Zeltiq Aesthetics Inc makes up approximately 0.32% of Handelsinvest Investeringsforvaltning’s portfolio.
Other Hedge Funds, Including , Finemark National Bank Trust boosted its stake in ZLTQ in the latest quarter, The investment management firm added 43 additional shares and now holds a total of 105 shares of Zeltiq Aesthetics Inc which is valued at $3,884. Quantitative Investment Management added ZLTQ to its portfolio by purchasing 41,500 company shares during the most recent quarter which is valued at $1,427,600. Zeltiq Aesthetics Inc makes up approx 0.06% of Quantitative Investment Management’s portfolio.Cam Group Holding As reduced its stake in ZLTQ by selling 15,000 shares or 10.0% in the most recent quarter. The Hedge Fund company now holds 135,000 shares of ZLTQ which is valued at $4,583,250. Zeltiq Aesthetics Inc makes up approx 0.08% of Cam Group Holding As’s portfolio.Calamos Advisors boosted its stake in ZLTQ in the latest quarter, The investment management firm added 675,913 additional shares and now holds a total of 696,038 shares of Zeltiq Aesthetics Inc which is valued at $23,435,599. Zeltiq Aesthetics Inc makes up approx 0.21% of Calamos Advisors’s portfolio. Hamilton Lane Advisors sold out all of its stake in ZLTQ during the most recent quarter. The investment firm sold 66,749 shares of ZLTQ which is valued $2,099,924.
Zeltiq Aesthetics Inc closed down -0.06 points or -0.16% at $37.78 with 9,34,959 shares getting traded on Monday. Post opening the session at $37.67, the shares hit an intraday low of $36.75 and an intraday high of $37.96 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Zeltiq Aesthetics Inc reported $-0.12 EPS for the quarter, missing the analyst consensus estimate by $ -0.08 based on the information available during the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.04. The company had revenue of $89.50 million for the quarter, compared to analysts expectations of $79.68 million. The company’s revenue was up 38.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.
Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Company shares were Reiterated by Maxim Group on Aug 9, 2016 to “Buy”, Firm has raised the Price Target to $ 48 from a previous price target of $40 .
ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.